I hear you. I had bought in to MRNA early as well - the biologist in me was optimistic about the possibilities of using messenger RNA, but the investor in me was concerned about the unknowns - I decided that leronlimab, as a molecule introduced into our body like any other, was a safer bet than reprogramming our cells directly. I still feel like it was a good decision. MRNA could have gone sideways.